GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Glenmark Pharmaceuticals Ltd (NSE:GLENMARK) » Definitions » Days Payable

Glenmark Pharmaceuticals (NSE:GLENMARK) Days Payable : 169.48 (As of Dec. 2023)


View and export this data going back to 2000. Start your Free Trial

What is Glenmark Pharmaceuticals Days Payable?

Glenmark Pharmaceuticals's average Accounts Payable for the three months ended in Dec. 2023 was ₹19,173 Mil. Glenmark Pharmaceuticals's Cost of Goods Sold for the three months ended in Dec. 2023 was ₹10,323 Mil. Hence, Glenmark Pharmaceuticals's Days Payable for the three months ended in Dec. 2023 was 169.48.

The historical rank and industry rank for Glenmark Pharmaceuticals's Days Payable or its related term are showing as below:

NSE:GLENMARK' s Days Payable Range Over the Past 10 Years
Min: 154.59   Med: 198.8   Max: 292.23
Current: 154.59

During the past 13 years, Glenmark Pharmaceuticals's highest Days Payable was 292.23. The lowest was 154.59. And the median was 198.80.

NSE:GLENMARK's Days Payable is ranked better than
77.28% of 977 companies
in the Drug Manufacturers industry
Industry Median: 86.82 vs NSE:GLENMARK: 154.59

Glenmark Pharmaceuticals's Days Payable declined from Dec. 2022 (200.90) to Dec. 2023 (169.48). It may suggest that Glenmark Pharmaceuticals accelerated paying its suppliers.


Glenmark Pharmaceuticals Days Payable Historical Data

The historical data trend for Glenmark Pharmaceuticals's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Glenmark Pharmaceuticals Days Payable Chart

Glenmark Pharmaceuticals Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Days Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 198.33 196.59 199.26 172.88 174.92

Glenmark Pharmaceuticals Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 200.90 122.52 177.73 146.06 169.48

Competitive Comparison of Glenmark Pharmaceuticals's Days Payable

For the Drug Manufacturers - Specialty & Generic subindustry, Glenmark Pharmaceuticals's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Glenmark Pharmaceuticals's Days Payable Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Glenmark Pharmaceuticals's Days Payable distribution charts can be found below:

* The bar in red indicates where Glenmark Pharmaceuticals's Days Payable falls into.



Glenmark Pharmaceuticals Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Glenmark Pharmaceuticals's Days Payable for the fiscal year that ended in Mar. 2023 is calculated as

Days Payable (A: Mar. 2023 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Mar. 2022 ) + Accounts Payable (A: Mar. 2023 )) / count ) / Cost of Goods Sold (A: Mar. 2023 )*Days in Period
=( (22886.62 + 23918.61) / 2 ) / 48832.8*365
=23402.615 / 48832.8*365
=174.92

Glenmark Pharmaceuticals's Days Payable for the quarter that ended in Dec. 2023 is calculated as:

Days Payable (Q: Dec. 2023 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Sep. 2023 ) + Accounts Payable (Q: Dec. 2023 )) / count ) / Cost of Goods Sold (Q: Dec. 2023 )*Days in Period
=( (19172.73 + 0) / 1 ) / 10322.58*365 / 4
=19172.73 / 10322.58*365 / 4
=169.48

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Glenmark Pharmaceuticals Days Payable Related Terms

Thank you for viewing the detailed overview of Glenmark Pharmaceuticals's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.


Glenmark Pharmaceuticals (NSE:GLENMARK) Business Description

Traded in Other Exchanges
Address
Glenmark House, B. D. Sawant Marg, Chakala, Off Western Express Highway, Andheri (East), Mumbai, IND, 400099
Glenmark Pharmaceuticals Ltd is a specialty and generic drug manufacturing company. The company's research and development activity is focused on generating intellectual property assets that will help address unmet medical needs. Glenmark's product categories include novel molecular entities, formulations, and API products. The company considers merger and acquisition investment to be a potential component for expanding its research, development, manufacturing, and marketing capabilities.

Glenmark Pharmaceuticals (NSE:GLENMARK) Headlines

No Headlines